The data indicate a possible link between the TIM-3/Gal-9 pathway and SLE clinical phenotypes, and further investigation of the TIM-3 pathway in SLE pathophysiology is warranted. The gene discussed is LGALS9; the disease is systemic lupus erythematosus.